Please login to the form below

Social listening report: Is COVID-19 impacting clinical trial recruitment?

The short answer, perhaps obviously, is yes.

Here at COUCH Health, we’ve been doing some social listening to work out how the COVID-19 pandemic is affecting clinical trials and product development for other conditions. Of course, at the moment, most online discussions about clinical research surround the latest developments in COVID-19 trials. Everyone is working hard to investigate vaccines, better diagnostic tests and treatments. The most common emotion revealed in our analysis was fear. And this isn’t surprising, since the uncertainty of the pandemic is affecting us all in so many ways.

Outside of COVID-19 research, clinical trials are being impacted regardless of indication. The FDA has encouraged clinical trials to pause unless they serve an immediate benefit. Some trials are taking the opportunity to decentralise their study assessments, using saliva collection kits that can be used at home and posted for testing instead. That way, the trial can keep move forwards and enrolment can still be encouraged. But it’s not just the routine appointments for participants that are being affected:

  • Screening is unable to go ahead as patients can’t visit study clinics and many clinicians are working from home, where they can.
  • Research groups that run lab work are putting operations on hold to devote resources to COVID-19.
  • COVID-19 testing is not part of trial protocols and patients may need to be removed from study populations for safety reasons.

Our insights have revealed that lots of people are worried about attending appointments because of the risks of COVID-19. These feelings would undoubtedly translate to the clinical trials, too.

“Must admit I am not looking forward to going to the hospital as I believe they could be riddled with COVID-19.”
– MS patient

And a survey in the US found that almost 40% of study sites believe that patients will be less willing to consentto take part in a new clinical trial.

Like never before, COVID-19 has forced the pharmaceutical industry to step up, expedite processes and re-evaluate priorities. While this does mean that resources are being diverted to focus on COVID-19, it’s equally important that progress doesn’t stop for other conditions. Clinical trial teams will need to adapt, decentralise, and go the extra mile to reassure patients that taking part is safe.

For more insights on how the clinical trial space is changing in light of COVID-19, take a look at more of our findings by downloading the document. And if you’re wondering how your study could benefit from improved patient engagement or virtual activities during these challenging times, we’re here to help.

This blog was originally posted here:


  COVID-19 Social Listening Report
PDF File: 1.8 MB

18th April 2020


  COVID-19 Social Listening Report
PDF File: 1.8 MB



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

COUCH Health publishes report to encourage patient engagement in the MedTech sector
Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.
COUCH Health
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health